OM:SEDANA

Stock Analysis Report

Executive Summary

Sedana Medical AB (publ), a medical technology company, develops, markets, and sells medical devices in Sweden and internationally.

Snowflake

Fundamentals

Flawless balance sheet with limited growth.


Similar Companies

Share Price & News

How has Sedana Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-3.0%

SEDANA

1.7%

SE Medical Equipment

3.4%

SE Market


1 Year Return

49.0%

SEDANA

32.2%

SE Medical Equipment

9.1%

SE Market

Return vs Industry: SEDANA exceeded the Swedish Medical Equipment industry which returned 32.2% over the past year.

Return vs Market: SEDANA exceeded the Swedish Market which returned 9.1% over the past year.


Shareholder returns

SEDANAIndustryMarket
7 Day-3.0%1.7%3.4%
30 Day3.7%0.6%0.6%
90 Day4.5%-2.1%2.9%
1 Year49.0%49.0%33.6%32.2%13.7%9.1%
3 Yearn/a44.0%26.5%31.2%11.6%
5 Yearn/a69.4%41.4%64.2%29.2%

Price Volatility Vs. Market

How volatile is Sedana Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Sedana Medical undervalued compared to its fair value and its price relative to the market?

12.27x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate SEDANA's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate SEDANA's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: SEDANA is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: SEDANA is unprofitable, so we can't compare its PE Ratio to the Swedish market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate SEDANA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SEDANA is overvalued based on its PB Ratio (12.3x) compared to the SE Medical Equipment industry average (4.5x).


Next Steps

Future Growth

How is Sedana Medical forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

72.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SEDANA is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SEDANA is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SEDANA is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SEDANA's revenue (35.2% per year) is forecast to grow faster than the Swedish market (4.5% per year).

High Growth Revenue: SEDANA's revenue (35.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if SEDANA's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Sedana Medical performed over the past 5 years?

-77.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: SEDANA is unprofitable, and losses have increased over the past 5 years at a rate of -77.6% per year.

Accelerating Growth: Unable to compare SEDANA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SEDANA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.3%).


Return on Equity

High ROE: SEDANA has a negative Return on Equity (-4.97%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: SEDANA is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: SEDANA is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Sedana Medical's financial position?


Financial Position Analysis

Short Term Liabilities: SEDANA's short term assets (SEK152.0M) exceeds its short term liabilities (SEK17.8M)

Long Term Liabilities: SEDANA has no long term liabilities


Debt to Equity History and Analysis

Debt Level: SEDANA is debt free.

Reducing Debt: SEDANA had no debt 5 years ago.


Balance Sheet

Inventory Level: SEDANA has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if SEDANA's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SEDANA has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SEDANA has sufficient cash runway for 2.981924 years if free cash flow continues to reduce at historical rates of -60.7% each year.


Next Steps

Dividend

What is Sedana Medical's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.8%markettop25%4.7%industryaverage1.1%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate SEDANA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate SEDANA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if SEDANA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SEDANA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SEDANA's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

What is the CEO of Sedana Medical's salary, the management and board of directors tenure and is there insider trading?

1.8yrs

Average management tenure


CEO

Christer Ahlberg (48yo)

2.7yrs

Tenure

0

Mr. Christer Ahlberg serves as the President and Chief Executive Officer of Sedana Medical AB (publ). He serves as CEO of Sedana Medical AB (publ) since February 01, 2017. Mr. Ahlberg has more than 10 year ...


CEO Compensation Analysis

Compensation vs. Market: Insufficient data to establish whether Christer's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensation vs Earnings: Insufficient data to compare Christer's compensation with company performance.


Management Age and Tenure

1.8yrs

Average Tenure

48yo

Average Age

Experienced Management: SEDANA's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Age and Tenure

11.8yrs

Average Tenure

64yo

Average Age

Experienced Board: SEDANA's board of directors are seasoned and experienced ( 11.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Sellkr6,685,57305 Jun 19
Thomas Eklund
EntityIndividual
Role
Chairman of the Board
Chairman of the Board
Shares57,540
Max Pricekr116.19
Sellkr80,106,22326 Nov 18
Michael Ryan
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,068,083
Max Pricekr75.00

Ownership Breakdown


Management Team

  • Christer Ahlberg (48yo)

    President & CEO

    • Tenure: 2.7yrs
  • Maria Engström (47yo)

    Chief Financial Officer

    • Tenure: 2.7yrs
  • Ron Farrell (63yo)

    VP and Head of R&D and Quality

    • Tenure: 0yrs
  • Robert Dorp (49yo)

    VP & Head of Sales

    • Tenure: 0yrs
  • Peter Sackey (48yo)

    Chief Medical Officer

    • Tenure: 1.8yrs
  • Gunilla Mickelsson (48yo)

    Head of Marketing Director

    • Tenure: 1yrs
  • Donat O’Brien

    General Manager Manufacturing

    • Tenure: 0.08yrs

Board Members

  • Sten Gibeck (76yo)

    Director

    • Tenure: 14.8yrs
  • Ola Magnusson (71yo)

    Director

    • Tenure: 14.8yrs
  • Thomas Eklund (52yo)

    Chairman of the Board

    • Tenure: 5.8yrs
  • Bengt Julander (66yo)

    Director

    • Tenure: 8.8yrs
  • Eva Walder (56yo)

    Director

    • Tenure: 1.4yrs
  • Mike Ryan (62yo)

    Director

    • Tenure: 14.8yrs

Company Information

Sedana Medical AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sedana Medical AB (publ)
  • Ticker: SEDANA
  • Exchange: OM
  • Founded: 2005
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: kr3.042b
  • Shares outstanding: 22.74m
  • Website: https://www.sedanamedical.com

Number of Employees


Location

  • Sedana Medical AB (publ)
  • Vendevägen 87
  • Danderyd
  • Stockholm County
  • 182 32
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SEDANAOM (OMX Nordic Exchange Stockholm)YesShare CapitalSESEKJun 2017
7D2DB (Deutsche Boerse AG)YesShare CapitalDEEURJun 2017

Biography

Sedana Medical AB (publ), a medical technology company, develops, markets, and sells medical devices in Sweden and internationally. The company offers AnaConDa and AnaConDa-S, which are disposable medical  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/15 21:47
End of Day Share Price2019/10/15 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.